Keywords: biofusion, signs, research, agreement, sheffield, uni, uk-headquartered
Biofusion signs research agreement with Sheffield Uni
Article | 14 July 2008
UK-headquartered Biofusion, which is focused on the commercialization of intellectual property, says that it has signed a new 10-year exclusive ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
